Pfizer CEO Albert Bourla said on Monday he had tested positive for Covid-19 and was experiencing very mild symptoms.
Bourla, 60, said he had started a course of the company’s oral Covid-19 antiviral treatment, Paxlovid, and was isolating and following all public health precautions.
“I am confident that I will have a speedy recovery,” Bourla said in a statement.
Paxlovid is an antiviral medication that is used to treat high-risk people, such as older patients.
Bourla has received four doses of the Covid vaccine developed by Pfizer and its German partner BioNTech.